Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2027-10
Enrollment target: 30 participants
Locations
Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China, Tianjin, Tianjin Municipality, China